Identification of new autoantibody specificities directed at proteins involved in the transforming growth factor β pathway in patients with systemic sclerosis

Arthritis Research and Therapy

Volumn 13, Issue 3, 2011, Pages

  Bussone, Guillaume ^a   Dib, Hanadi ^a   Tamby, Mathieu C ^a   Broussard, Cedric ^a   Federici, Christian ^a   Woimant, Geneviève ^b   Camoin, Luc ^a   Guillevin, Loïc ^c   Mouthon, Luc ^a,c  

^a INSTITUT COCHIN   (France)

^b HÔPITAL SAINT VINCENT DE PAUL   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ENOLASE; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; AUTOANTIGEN; CALRETICULIN; COFILIN 1; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN L; IMMUNOGLOBULIN G; LAMIN A; LAMIN C; NUCLEAR PROTEIN; PEROXIREDOXIN 2; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA; TRIOSEPHOSPHATE ISOMERASE; BIOLOGICAL MARKER; PROTEOME;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN DETECTION; ARTICLE; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOBLOTTING; MASS SPECTROMETRY; PHENOTYPE; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEOMICS; SYSTEMIC SCLEROSIS; TWO DIMENSIONAL ELECTROPHORESIS; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; IMMUNOPHENOTYPING; ISOLATION AND PURIFICATION; LARYNX TUMOR; METABOLISM; METHODOLOGY; PROGNOSIS; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANTIBODIES, ANTINUCLEAR; ANTIBODY SPECIFICITY; AUTOANTIGENS; BIOLOGICAL MARKERS; CELL LINE, TUMOR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOGLOBULIN G; IMMUNOPHENOTYPING; LARYNGEAL NEOPLASMS; NUCLEAR PROTEINS; PROGNOSIS; PROTEOME; PROTEOMICS; SCLERODERMA, SYSTEMIC; SIGNAL TRANSDUCTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRANSFORMING GROWTH FACTOR BETA;

EID: 79955836706     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3336     Document Type: Article

References (47)

1. Tamby MC, Chanseaud Y, Guillevin L, Mouthon L. New insights into the pathogenesis of systemic sclerosis. Autoimmun Rev 2003, 2:152-157. 10.1016/S1568-9972(03)00004-1, 12848956.
2. Steen VD. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 2005, 35:35-42. 10.1016/j.semarthrit.2005.03.005, 16084222.
3. Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med 2009, 360:1989-2003. 10.1056/NEJMra0806188, 19420368.
4. Chizzolini C, Raschi E, Rezzonico R, Testoni C, Mallone R, Gabrielli A, Facchini A, Del Papa N, Borghi MO, Dayer JM, Meroni PL. Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis. Arthritis Rheum 2002, 46:1602-1613. 10.1002/art.10361, 12115192.
5. Baroni SS, Santillo M, Bevilacqua F, Luchetti M, Spadoni T, Mancini M, Fraticelli P, Sambo P, Funaro A, Kazlauskas A, Avvedimento EV, Gabrielli A. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med 2006, 354:2667-2676. 10.1056/NEJMoa052955, 16790699.
6. Tamby MC, Servettaz A, Tamas N, Reinbolt J, Caux F, Meyer O, Allanore Y, Kahan A, Guillevin L, Mouthon L. IgG from patients with systemic sclerosis bind to DNA antitopoisomerase 1 in normal human fibroblasts extracts. Biologics 2008, 2:583-591. 2721369, 19707389.
7. Ihn H, Sato S, Fujimoto M, Igarashi A, Yazawa N, Kubo M, Kikuchi K, Takehara K, Tamaki K. Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosis. Clin Exp Immunol 2000, 119:203-209. 10.1046/j.1365-2249.2000.01115.x, 1905540, 10606984.
8. García de la Peña-Lefebvre P, Chanseaud Y, Tamby MC, Reinbolt J, Batteux F, Allanore Y, Kahan A, Meyer O, Benveniste O, Boyer O, Guillevin L, Boissier MC, Mouthon L. IgG reactivity with a 100-kDa tissue and endothelial cell antigen identified as topoisomerase 1 distinguishes between limited and diffuse systemic sclerosis patients. Clin Immunol 2004, 111:241-251. 10.1016/j.clim.2004.01.005, 15183145.
9. Mihai C, Tervaert JW. Anti-endothelial cell antibodies in systemic sclerosis. Ann Rheum Dis 2010, 69:319-324. 10.1136/ard.2008.102400, 20107031.
10. Terrier B, Tamby MC, Camoin L, Guilpain P, Broussard C, Bussone G, Yaici A, Hotellier F, Simonneau G, Guillevin L, Humbert M, Mouthon L. Identification of target antigens of antifibroblast antibodies in pulmonary arterial hypertension. Am J Respir Crit Care Med 2008, 177:1128-1134. 10.1164/rccm.200707-1015OC, 18276943.
11. Servettaz A, Guilpain P, Camoin L, Mayeux P, Broussard C, Tamby MC, Tamas N, Kaveri SV, Guillevin L, Mouthon L. Identification of target antigens of antiendothelial cell antibodies in healthy individuals: a proteomic approach. Proteomics 2008, 8:1000-1008. 10.1002/pmic.200700794, 18240136.
12. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254. 10.1016/0003-2697(76)90527-3, 942051.
13. Bussone G, Dib H, Dimitrov JD, Camoin L, Broussard C, Tamas N, Guillevin L, Kaveri SV, Mouthon L. Identification of target antigens of self-reactive IgG in intravenous immunoglobulin preparations. Proteomics 2009, 9:2253-2262. 10.1002/pmic.200800819, 19296548.
14. Guilpain P, Servettaz A, Tamby MC, Chanseaud Y, Tamas N, Garcia de la Pena-Lefebvre P, Broussard C, Guillevin L, Camoin L, Mouthon L. A combined SDS-PAGE and proteomics approach to identify target autoantigens in healthy individuals and patients with autoimmune diseases. Ann N Y Acad Sci 2007, 1109:538-549. 10.1196/annals.1398.060, 17785343.
15. ExPASy Proteomics Server. , http://www.expasy.org
16. Ariadne Pathway Studio. , http://www.ariadnegenomics.com/products/pathway-studio/
17. Giusti L, Bazzichi L, Baldini C, Ciregia F, Mascia G, Giannaccini G, Del Rosso M, Bombardieri S, Lucacchini A. Specific proteins identified in whole saliva from patients with diffuse systemic sclerosis. J Rheumatol 2007, 34:2063-2069.
18. Terrier B, Tamby MC, Camoin L, Guilpain P, Berezne A, Tamas N, Broussard C, Hotellier F, Humbert M, Simonneau G, Guillevin L, Mouthon L. Antifibroblast antibodies from systemic sclerosis patients bind to α-enolase and are associated with interstitial lung disease. Ann Rheum Dis 2010, 69:428-433. 10.1136/ard.2008.104299, 19293162.
19. Bussone G, Mouthon L. Interstitial lung disease in systemic sclerosis. Autoimmun Rev 2011, 10:248-255. 10.1016/j.autrev.2010.09.012, 20863911.
20. Svegliati S, Cancello R, Sambo P, Luchetti M, Paroncini P, Orlandini G, Discepoli G, Paterno R, Santillo M, Cuozzo C, Cassano S, Avvedimento EV, Gabrielli A. Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK1/2: amplification of ROS and Ras in systemic sclerosis fibroblasts. J Biol Chem 2005, 280:36474-36482. 10.1074/jbc.M502851200, 16081426.
21. Dalpke AH, Thomssen R, Ritter K. Oxidative injury to endothelial cells due to Epstein-Barr virus-induced autoantibodies against manganese superoxide dismutase. J Med Virol 2003, 71:408-416. 10.1002/jmv.10501, 12966547.
22. Scott JL, Gabrielides C, Davidson RK, Swingler TE, Clark IM, Wallis GA, Boot-Handford RP, Kirkwood TB, Taylor RW, Young DA. Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease. Ann Rheum Dis 2010, 69:1502-1510. 10.1136/ard.2009.119966, 20511611.
23. Lefranc D, Launay D, Dubucquoi S, de Seze J, Dussart P, Vermersch M, Hachulla E, Hatron PY, Vermersch P, Mouthon L, Prin L. Characterization of discriminant human brain antigenic targets in neuropsychiatric systemic lupus erythematosus using an immunoproteomic approach. Arthritis Rheum 2007, 56:3420-3432. 10.1002/art.22863, 17907141.
24. Xiang Y, Sekine T, Nakamura H, Imajoh-Ohmi S, Fukuda H, Nishioka K, Kato T. Proteomic surveillance of autoimmunity in osteoarthritis: identification of triosephosphate isomerase as an autoantigen in patients with osteoarthritis. Arthritis Rheum 2004, 50:1511-1521. 10.1002/art.20189, 15146421.
25. Eriksson M, Brown WT, Gordon LB, Glynn MW, Singer J, Scott L, Erdos MR, Robbins CM, Moses TY, Berglund P, Dutra A, Pak E, Durkin S, Csoka AB, Boehnke M, Glover TW, Collins FS. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 2003, 423:293-298. 10.1038/nature01629, 12714972.
26. McClintock D, Gordon LB, Djabali K. Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-Lamin A G608G antibody. Proc Natl Acad Sci USA 2006, 103:2154-2159. 10.1073/pnas.0511133103, 1413759, 16461887.
27. Reeves WH, Chaudhary N, Salerno A, Blobel G. Lamin B autoantibodies in sera of certain patients with systemic lupus erythematosus. J Exp Med 1987, 165:750-762. 10.1084/jem.165.3.750, 2188284, 3546581.
28. Senecal JL, Rauch J, Grodzicky T, Raynauld JP, Uthman I, Nava A, Guimond M, Raymond Y. Strong association of autoantibodies to human nuclear lamin B1 with lupus anticoagulant antibodies in systemic lupus erythematosus. Arthritis Rheum 1999, 42:1347-1353. 10.1002/1529-0131(199907)42:7<1347::AID-ANR7>3.0.CO;2-#, 10403261.
29. McKeon FD, Tuffanelli DL, Fukuyama K, Kirschner MW. Autoimmune response directed against conserved determinants of nuclear envelope proteins in a patient with linear scleroderma. Proc Natl Acad Sci USA 1983, 80:4374-4378. 10.1073/pnas.80.14.4374, 384040, 6192431.
30. Siapka S, Patrinou-Georgoula M, Vlachoyiannopoulos PG, Guialis A. Multiple specificities of autoantibodies against hnRNP A/B proteins in systemic rheumatic diseases and hnRNP L as an associated novel autoantigen. Autoimmunity 2007, 40:223-233. 10.1080/08916930701352357, 17453722.
31. Thébault S, Gilbert D, Hubert M, Drouot L, Machour N, Lange C, Charlionet R, Tron F. Orderly pattern of development of the autoantibody response in (New Zealand White × BXSB)F1 lupus mice: characterization of target antigens and antigen spreading by two-dimensional gel electrophoresis and mass spectrometry. J Immunol 2002, 169:4046-4053.
32. Olahova M, Taylor SR, Khazaipoul S, Wang J, Morgan BA, Matsumoto K, Blackwell TK, Veal EA. A redox-sensitive peroxiredoxin that is important for longevity has tissue- and stress-specific roles in stress resistance. Proc Natl Acad Sci USA 2008, 105:19839-19844. 10.1073/pnas.0805507105, 2604961, 19064914.
33. Choi MH, Lee IK, Kim GW, Kim BU, Han YH, Yu DY, Park HS, Kim KY, Lee JS, Choi C, Bae YS, Lee BI, Rhee SG, Kang SW. Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II. Nature 2005, 435:347-353. 10.1038/nature03587, 15902258.
34. Karasawa R, Kurokawa MS, Yudoh K, Masuko K, Ozaki S, Kato T. Peroxiredoxin 2 is a novel autoantigen for anti-endothelial cell antibodies in systemic vasculitis. Clin Exp Immunol 2010, 161:459-470. 10.1111/j.1365-2249.2010.04218.x, 20646000.
35. Lee MY, San Martin A, Mehta PK, Dikalova AE, Garrido AM, Datla SR, Lyons E, Krause KH, Banfi B, Lambeth JD, Lassègue B, Griendling KK. Mechanisms of vascular smooth muscle NADPH oxidase 1 (Nox1) contribution to injury-induced neointimal formation. Arterioscler Thromb Vasc Biol 2009, 29:480-487. 10.1161/ATVBAHA.108.181925, 2734189, 19150879.
36. San Martín A, Lee MY, Williams HC, Mizuno K, Lassègue B, Griendling KK. Dual regulation of cofilin activity by LIM kinase and Slingshot-1L phosphatase controls platelet-derived growth factor-induced migration of human aortic smooth muscle cells. Circ Res 2008, 102:432-438. 10.1161/CIRCRESAHA.107.158923, 18096821.
37. Ooka S, Nakano H, Matsuda T, Okamoto K, Suematsu N, Kurokawa MS, Ohtani-Kaneko R, Masuko K, Ozaki S, Kato T. Proteomic surveillance of autoantigens in patients with Behçet's disease by a proteomic approach. Microbiol Immunol 2010, 54:354-361. 10.1111/j.1348-0421.2010.00215.x, 20536734.
38. Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL, Castedo M, Mignot G, Panaretakis T, Casares N, Métivier D, Larochette N, van Endert P, Ciccosanti F, Piacentini M, Zitvogel L, Kroemer G. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 2007, 13:54-61. 10.1038/nm1523, 17187072.
39. Seddiki N, Nato F, Lafaye P, Amoura Z, Piette JC, Mazie JC. Calreticulin, a potential cell surface receptor involved in cell penetration of anti-DNA antibodies. J Immunol 2001, 166:6423-6429.
40. Tuckova L, Karska K, Walters JR, Michalak M, Rossmann P, Krupickova S, Verdu EF, Saalman R, Hanson LA, Tlaskalova-Hogenova H. Anti-gliadin antibodies in patients with celiac disease cross-react with enterocytes and human calreticulin. Clin Immunol Immunopathol 1997, 85:289-296. 10.1006/clin.1997.4429, 9400629.
41. van den Berg RH, Siegert CE, Faber-Krol MC, Huizinga TW, van Es LA, Daha MR. Anti-C1q receptor/calreticulin autoantibodies in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1998, 111:359-364. 10.1046/j.1365-2249.1998.00473.x, 1904908, 9486404.
42. Casciola-Rosen L, Wigley F, Rosen A. Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: implications for pathogenesis. J Exp Med 1997, 185:71-79. 10.1084/jem.185.1.71, 2196102, 8996243.
43. Wright WD, Roti Roti JL. Resolution of DNA topoisomerase II by two-dimensional polyacrylamide gel electrophoresis and Western blotting. Anal Biochem 1992, 204:124-130. 10.1016/0003-2697(92)90150-6, 1325132.
44. Tamby MC, Servettaz A, Guilpain P, Tamas N, Berezne A, Batteux F, Reinbolt J, Guillevin L, Weill B, Mouthon L. Immunoblotting on HEp-2 cells increases the detection of antitopoisomerase 1 antibodies in patients with systemic sclerosis. Clin Immunol 2007, 123:82-88. 10.1016/j.clim.2006.12.003, 17258939.
45. Servettaz A, Tamby MC, Guilpain P, Reinbolt J, Garcia de la Peña-Lefebvre P, Allanore Y, Kahan A, Meyer O, Guillevin L, Mouthon L. Anti-endothelial cell antibodies from patients with limited cutaneous systemic sclerosis bind to centromeric protein B (CENP-B). Clin Immunol 2006, 120:212-219. 10.1016/j.clim.2006.02.006, 16580263.
46. Kuwana M, Kaburaki J, Medsger TA, Wright TM. An immunodominant epitope on DNA topoisomerase I is conformational in nature: heterogeneity in its recognition by systemic sclerosis sera. Arthritis Rheum 1999, 42:1179-1188. 10.1002/1529-0131(199906)42:6<1179::AID-ANR14>3.0.CO;2-E, 10366110.
47. Kuwana M, Kimura K, Kawakami Y. Identification of an immunodominant epitope on RNA polymerase III recognized by systemic sclerosis sera: application to enzyme-linked immunosorbent assay. Arthritis Rheum 2002, 46:2742-2747. 10.1002/art.10521, 12384934.